Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - RETAINED EARNINGS
Retained Earnings ITCI - Intra-Cellular Therapies, Inc.
-1.62 B
LAST VALUE
-15.07%
2 YEAR CAGR
-23.52%
5 YEAR CAGR
-39.59%
10 YEAR CAGR